proliferation, apoptosis, metabolism, and differentiation. [1,2] However, the variety of strategies to control cell-biomaterial interactions able to transmit mechanical cues from the microenvironment to the cells within engineered tissue constructs has remained limited and near-exclusively relied on cell adhesion. Biomaterials are typically endowed with bioligands that bind to cell adhesion molecules (CAMs; e.g., integrins, cadherins, and selectins). The integrinbinding tripeptide arginine-glycine-aspartic acid (RGD) [3] has been most commonly used as cell-adhesive moiety, but also numerous alternative cell-adhesive nucleotides, [4] peptides, [5] and proteins including antibodies [6] and amyloid-like lysozyme [7] have been explored. However, the constitutively active binding nature of these cell-adhesive bioligands has been associated with adverse effects such as increased fibrous capsule formation and chronic inflammation upon implantation. [8,9] Dynamic material modification strategies that display cell-adhesive bioligands with precise spatial and temporal control have been developed to address this challenge. However, once activated, their cell-adhesive properties are continuously active and can only be annihilated using Cell-matrix interactions govern cell behavior and tissue function by facilitating transduction of biomechanical cues. Engineered tissues often incorporate these interactions by employing cell-adhesive materials. However, using constitutively active cell-adhesive materials impedes control over cell fate and elicits inflammatory responses upon implantation. Here, an alternative cell-material interaction strategy that provides mechanotransducive properties via discrete inducible on-cell crosslinking (DOCKING) of materials, including those that are inherently non-cell-adhesive, is introduced. Specifically, tyramine-functionalized materials are tethered to tyrosines that are naturally present in extracellular protein domains via enzyme-mediated oxidative crosslinking. Temporal control over the stiffness of on-cell tethered 3D microniches reveals that DOCKING uniquely enables lineage programming of stem cells by targeting adhesome-related mechanotransduction pathways acting independently of cell volume changes and spreading. In short, DOCKING represents a bioinspired and cytocompatible cell-tethering strategy that offers new routes to study and engineer cell-material interactions, thereby advancing applications ranging from drug delivery, to cell-based therapy, and cultured meat.The ORCID identification number(s) for the author(s) of this article can be found under https://doi.org/10.1002/adma.202102660.